To enhance service speed and avoid tariff delays, we've opened a US warehouse. All US orders ship directly from our US facility.
| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC1731 | Demethoxyviridin |
Potent inhibitor of PI3 kinases
More description
|
|
| DCC1730 | Delta-tocopherol |
Vitamin E variant, inhibiting prostate adenocarcinoma, lung tumorigenesis, promoting thermogenic gene expression via PGC-1α upregulation, preventing methylglyoxal-induced apoptosis by reducing ROS generation and inhibiting apoptotic signaling cascades
More description
|
|
| DCC1729 | Delcasertib |
Novel selective δ-protein kinase C inhibitor
More description
|
|
| DCC1728 | Dehydrorabelomycin |
Natural polyketide matabolite
More description
|
|
| DCC1727 | Degrader Bt1 |
Novel selective degrader of BCR-ABL over c-ABL in leukemia cancer cells
More description
|
|
| DCC1726 | Deferoxamine Hydrochloride |
Iron chelating agent, chelating iron from intra-lysosomal ferritin and hemosiderin forming ferrioxamine, a water-soluble chelate excreted by the kidneys and in the feces via the bile
More description
|
|
| DCC1725 | Deferasirox Ferrate(iii) Tripotassium Complex |
Deferasirox iron complex
More description
|
|
| DCC1724 | Debio-1452-nh3 |
Novel potent inhibitor of the enoyl-acyl carrier protein reductase FabI, reducing bacterial burden in mice and rescuing mice from lethal infections with clinical isolates of Acinetobacter baumannii, Klebsiella pneumoniae and E. coli
More description
|
|
| DCC1723 | Deac-pda-atp |
Fluorophore to myosin or actomyosin
More description
|
|
| DCC1722 | Deacm-caged D-luciferin |
Coumarin-caged D-luciferin, being excited in the caged group only by light of wavelength ranging within 400-430 nm
More description
|
|
| DCC1721 | Dea Nonoate Sodium Salt |
NO donor, generating a controlled release of nitric oxide in solution.
More description
|
|
| DCC1720 | Ddr-trk-1n |
Negative control for DDR-TRK-1
More description
|
|
| DCC1719 | Ddri-18 |
Inhibitor of nonhomologous end-joining (NHEJ) DNA repair following double strand DNA breaks induced by ionizing radiation, enhancing the effects of DNA-damaging cancer drugs like etoposide, camptothecin and doxorubicin
More description
|
|
| DCC1718 | Ddr1-in-2 |
Potent and selective DDR1 receptor tyrosine kinase inhibitor
More description
|
|
| DCC1717 | ddpm-1457 |
Potent mGAT4 inhibitor
More description
|
|
| DCC1716 | Ddo-7204 |
Novel Nrf2 activator
More description
|
|
| DCC1715 | Ddo-7132 |
Novel NQO1 substrate, inhibiting cancer cell (NQO1-rich A549 cell line) growth
More description
|
|
| DCC1714 | Ddo-2213 |
Novel Potent and Orally Bioavailable Inhibitor of the WDR5-Mixed Lineage Leukemia 1 (MLL1) Protein-Protein Interaction for the Treatment of MLL Fusion Leukemia
More description
|
|
| DCC1713 | Ddo-2117 |
Novel potent blocker of mixed lineage leukemia 1 (MLL1)-WDR5 interaction, inhibiting MLL1 complex H3K4 methyltransferase activity
More description
|
|
| DCC1712 | Ddhctp Sodium Salt |
Novel potent and broad-spectrum antiviral agent, acting as a chain terminator for viral RNA polymerase
More description
|
|
| DCC1711 | Ddd100097 |
Potent inhibitor of Trypanosoma brucei N-myristoyltransferase (TbNMT) with markedly improved blood-brain barrier permeability
More description
|
|
| DCC1710 | Ddd-028 |
Potent potential non-opioid, non-cannabinoid analgesic for neuropathic and inflammatory pain
More description
|
|
| DCC1709 | Ddd01035881 |
Novel transmission blocker of antimalarials, targeting male gametes
More description
|
|
| DCC1708 | Ddd00015314 |
Novel activator of the GUS reporter activity, specific increasing in stumpy reporter gene expression
More description
|
|
| DCC1707 | Ddc4002 |
First-generation allosteric EGFR inhibitor, binding to the allosteric site of EGFR along with ATP that leads to inhibition of cell proliferation and arrest of EGFR L858R/T790M/C797S signalling
More description
|
|
| DCC1705 | Dd-04-015 |
Novel selective BTK degrader, demonstrating prolonged pharmacodynamic effects
More description
|
|
| DCC1704 | Dcz3112 |
Novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp90-Cdc37 interaction
More description
|
|
| DCC1703 | Dc-teadin02 |
Novel potent and selective TEAD autopalmitoylation inhibitor, inhibiting TEADs transcription activity and downstream gene expression
More description
|
|
| DCC1702 | Dc-s239 |
Novel, Potent and Selective Histone Methyltransferase SET7 Inhibitor
More description
|
|
| DCC1701 | Dc-s238 |
Novel, Potent and Selective Histone Methyltransferase SET7 Inhibitor
More description
|
|